Concentrations well beyond 100 nmol, and especially into the 1 µmol to 100 µmol range, for total testosterone are highly unlikely, even in those abusing testosterone for athletic/aesthetic purposes. While pharmacokinetic data gathered in humans administered varying doses of testosterone esters either intramuscularly or subcutaneously vary considerably depending upon the route of administration and sampling method, these data generally show that only quantities used as part of testosterone abuse are capable of reaching concentrations of 100 nmol or greater on a consistent basis. In healthy eugonadal men, [buy testosterone cream](https://zm.aosenhw.com/@carolgss250477) is produced primarily by the Leydig cells of the testicles and results in the total daily production of approximately 6–7 mg/day, although a range of 3–10 mg total [buy testosterone enanthate](https://khmerhd.tv/@shanaleitch67?page=about) production is often cited as well 1,2,3,4,5,6,7,8,9,10. For those prescribing testosterone gels, patient counseling and provider awareness of this potential cause of spuriously high testosterone serum concentrations is important. Three subsequent total serum testosterone concentrations have been between 244 ng/dL (8.5 nmol/L) and 644 ng/dL (22.3 nmol/L). At the time the high serum testosterone concentrations were measured, the average age of patients was 40.3 years with a standard deviation (SD) of ± 17.1 years. Formulations of testosterone other than intramuscular, topical gel, or transdermal patch were uncommon, with only 88 testosterone serum measurements (32 unique patients) in patients prescribed alternate formulations such as mucoadhesive buccal tablets or subcutaneous pellets. Some serum testosterone measurements (especially those ordered for children or female patients who generally have lower serum testosterone concentrations) were sent to ARUP Laboratories (Salt Lake City, [www.liveactionzone.com](https://www.liveactionzone.com/@merissa342501?page=about) UT) which analyzed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Certainly, those that may be using or even abusing testosterone may wish to be informed of potential serious adverse effects. Thus, in this instance the concentrations used in vitro are not reflective of what is seen in vivo in humans. While it can certainly be argued that the relationship between testosterone and SHBG is dynamic and can be altered in cases of exogenous administration (amongst other variables), ultimately what matters most is the available concentration in brain tissue (see Section 2.2). In fact, it is nearly 3 times greater than the upper limit of normal for total blood testosterone levels in eugonadal males 12,13,14. First, it should be noted that contrary to the claims of some authors , 100 nmol is not within any accepted physiological range for eugonadal males. While the adverse effects of [buy testosterone supplements](https://www.freakscene.net/smf/index.php?topic=10565.0)—and in a broader sense, all anabolic-androgenic steroids—are fairly well described, more recent attention has been devoted to potential neurological side effects 18,19. More research is needed as the currently available data are limited; however, what is available provides rather weak evidence to suggest that testosterone use or abuse has neurotoxic potential in humans. Three days later, total testosterone serum concentration was 384 ng/dL (13.3 nmol/L). Retrospective distribution of testosterone serum concentrations for patients either prescribed [testosterone for sale](http://gitlab.dev.jtyjy.com/kathitooth1170) medications or not on any medications. Flow diagram showing number of testosterone serum concentrations for all patients and also broken into categories. Diagnosis based on a single serum testosterone measurement is discouraged, since about 25 % of men with an initial serum testosterone concentration in the hypogonadal range will exhibit normal testosterone concentrations on subsequent measurements 2,11,12. Comparative studies involving newer testosterone formulations such as pellets or mucosal adhesive buccal tablets are limited . For example, a 1000 mg testosterone undeconoate preparation is marketed in Europe (Nebido®, Bayer, Berkshire, United Kingdom), while the closest equivalent in the United States is a 750 mg testosterone undeconate preparation (Aveed®, Endo International, Malvern, PA, United States) . There are multiple formulations and doses of injectable testosterone, with testosterone undeconoate having longer action than testosterone enanthate or cypionate . The University of Iowa Hospitals and Clinics (UIHC) are comprised of a 860-bed tertiary/quaternary care medical center with affiliated outpatient clinics at the central campus and at sites throughout the local geographic region. Intramuscular testosterone cypionate or enanthate have extended duration of action and are relatively inexpensive compared to other testosterone formulations , , . However, artifactually high serum testosterone concentrations in patients receiving topical testosterone gels can occur if the venipuncture site is contaminated by gel during the phlebotomy procedure. Health care providers should be aware of the possibility of topical gel contamination to avoid unnecessary downstream consequences of apparent supraphysiologic serum testosterone concentrations. On the other hand, patients prescribed topical [testosterone price](http://150.158.37.69:3000/aimeel2813504) therapy achieved lower serum testosterone concentrations at the beginning of treatment, but significant serum testosterone fluctuations were more likely to be observed. We performed chart review of the 65 patients identified in the EHR database as being prescribed topical gel testosterone in conjunction with a testosterone serum concentration of 1000 ng/dL or higher. This phenomenon was first reported in 2010 as a case report of two instances of spuriously elevated serum testosterone concentrations in a patient resulting from contamination of the antecubital fossa by testosterone gel prior to phlebotomy . Gel contamination should be considered as a possible cause of otherwise unexplained high testosterone serum concentration in patients receiving topical testosterone gel formulations. Out of 578 unique patients using testosterone topical gel, a total of 48 patients had at least 1 testosterone serum concentration exceed 1000 ng/dL.
Concentrations well beyond 100 nmol, and especially into the 1 µmol to 100 µmol range, for total testosterone are highly unlikely, even in those abusing testosterone for athletic/aesthetic purposes. While pharmacokinetic data gathered in humans administered varying doses of testosterone esters either intramuscularly or subcutaneously vary considerably depending upon the route of administration and sampling method, these data generally show that only quantities used as part of testosterone abuse are capable of reaching concentrations of 100 nmol or greater on a consistent basis. In healthy eugonadal men, [buy testosterone cream](https://zm.aosenhw.com/@carolgss250477) is produced primarily by the Leydig cells of the testicles and results in the total daily production of approximately 6–7 mg/day, although a range of 3–10 mg total [buy testosterone enanthate](https://khmerhd.tv/@shanaleitch67?page=about) production is often cited as well 1,2,3,4,5,6,7,8,9,10. For those prescribing testosterone gels, patient counseling and provider awareness of this potential cause of spuriously high testosterone serum concentrations is important. Three subsequent total serum testosterone concentrations have been between 244 ng/dL (8.5 nmol/L) and 644 ng/dL (22.3 nmol/L). At the time the high serum testosterone concentrations were measured, the average age of patients was 40.3 years with a standard deviation (SD) of ± 17.1 years. Formulations of testosterone other than intramuscular, topical gel, or transdermal patch were uncommon, with only 88 testosterone serum measurements (32 unique patients) in patients prescribed alternate formulations such as mucoadhesive buccal tablets or subcutaneous pellets. Some serum testosterone measurements (especially those ordered for children or female patients who generally have lower serum testosterone concentrations) were sent to ARUP Laboratories (Salt Lake City, [www.liveactionzone.com](https://www.liveactionzone.com/@merissa342501?page=about) UT) which analyzed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Certainly, those that may be using or even abusing testosterone may wish to be informed of potential serious adverse effects. Thus, in this instance the concentrations used in vitro are not reflective of what is seen in vivo in humans. While it can certainly be argued that the relationship between testosterone and SHBG is dynamic and can be altered in cases of exogenous administration (amongst other variables), ultimately what matters most is the available concentration in brain tissue (see Section 2.2). In fact, it is nearly 3 times greater than the upper limit of normal for total blood testosterone levels in eugonadal males 12,13,14. First, it should be noted that contrary to the claims of some authors , 100 nmol is not within any accepted physiological range for eugonadal males. While the adverse effects of [buy testosterone supplements](https://www.freakscene.net/smf/index.php?topic=10565.0)—and in a broader sense, all anabolic-androgenic steroids—are fairly well described, more recent attention has been devoted to potential neurological side effects 18,19. More research is needed as the currently available data are limited; however, what is available provides rather weak evidence to suggest that testosterone use or abuse has neurotoxic potential in humans. Three days later, total testosterone serum concentration was 384 ng/dL (13.3 nmol/L). Retrospective distribution of testosterone serum concentrations for patients either prescribed [testosterone for sale](http://gitlab.dev.jtyjy.com/kathitooth1170) medications or not on any medications. Flow diagram showing number of testosterone serum concentrations for all patients and also broken into categories. Diagnosis based on a single serum testosterone measurement is discouraged, since about 25 % of men with an initial serum testosterone concentration in the hypogonadal range will exhibit normal testosterone concentrations on subsequent measurements 2,11,12. Comparative studies involving newer testosterone formulations such as pellets or mucosal adhesive buccal tablets are limited . For example, a 1000 mg testosterone undeconoate preparation is marketed in Europe (Nebido®, Bayer, Berkshire, United Kingdom), while the closest equivalent in the United States is a 750 mg testosterone undeconate preparation (Aveed®, Endo International, Malvern, PA, United States) . There are multiple formulations and doses of injectable testosterone, with testosterone undeconoate having longer action than testosterone enanthate or cypionate . The University of Iowa Hospitals and Clinics (UIHC) are comprised of a 860-bed tertiary/quaternary care medical center with affiliated outpatient clinics at the central campus and at sites throughout the local geographic region. Intramuscular testosterone cypionate or enanthate have extended duration of action and are relatively inexpensive compared to other testosterone formulations , , . However, artifactually high serum testosterone concentrations in patients receiving topical testosterone gels can occur if the venipuncture site is contaminated by gel during the phlebotomy procedure. Health care providers should be aware of the possibility of topical gel contamination to avoid unnecessary downstream consequences of apparent supraphysiologic serum testosterone concentrations. On the other hand, patients prescribed topical [testosterone price](http://150.158.37.69:3000/aimeel2813504) therapy achieved lower serum testosterone concentrations at the beginning of treatment, but significant serum testosterone fluctuations were more likely to be observed. We performed chart review of the 65 patients identified in the EHR database as being prescribed topical gel testosterone in conjunction with a testosterone serum concentration of 1000 ng/dL or higher. This phenomenon was first reported in 2010 as a case report of two instances of spuriously elevated serum testosterone concentrations in a patient resulting from contamination of the antecubital fossa by testosterone gel prior to phlebotomy . Gel contamination should be considered as a possible cause of otherwise unexplained high testosterone serum concentration in patients receiving topical testosterone gel formulations. Out of 578 unique patients using testosterone topical gel, a total of 48 patients had at least 1 testosterone serum concentration exceed 1000 ng/dL.